AUC Appropriate Use Criteria Appropriateness Criteria Bladder Cancer CT MRI Muscle-invasive Bladder Cancer Staging Urothelial Carcinoma

Humans Laser Therapy Male Patient Selection Preoperative Period Prostatic Hyperplasia/complications/physiopathology *Quality of Life Transurethral Resection of Prostate/*adverse effects/methods Treatment Outcome Urinary Bladder Underactive/etiology/*physiopathology *Urodynamics *muscle hypertonia *prostate *prostatic hyperplasia *urethra

Aged Humans Male Middle Aged *Patient Selection Prostate/surgery Prostatic Hyperplasia Quality of Life *Transurethral Resection of Prostate Treatment Outcome Urinary Bladder Neck Obstruction *Urodynamics

Erectile Dysfunction Holmium Humans *Laser Therapy Lasers Solid-State Length of Stay Male Prostatectomy Prostatic Hyperplasia Quality of Life *Transurethral Resection of Prostate Urethral Stricture Urinary Bladder Urinary Incontinence Urinary Retention benign prostatic hyperplasia bipolar transurethral plasmakinetic prostatectomy transurethral holmium laser enucleation of the prostate

Benign Prostatic Hyperplasia Prostate Cancer Bladder Cancer Meta-Analysis

Humans Smoking/adverse effects/epidemiology *Non-Muscle Invasive Bladder Neoplasms *Urinary Bladder Neoplasms/epidemiology/etiology *Carcinoma Transitional Cell Prognosis Neoplasm Recurrence Local/epidemiology Current smoker Non-muscle-invasive bladder cancer Progression Recurrence Smoking

Humans Female *Urinary Bladder Neoplasms/pathology *Carcinoma Transitional Cell/pathology Urinary Bladder/pathology Prognosis Proportional Hazards Models Meta-analysis Muscle-invasive bladder urothelial carcinoma Non-muscle-invasive bladder urothelial carcinoma Sex

Humans Immune Checkpoint Inhibitors/therapeutic use *Carcinoma Transitional Cell/drug therapy *Urinary Bladder Neoplasms/drug therapy Proportional Hazards Models Eastern Cooperative Oncology Group Immune checkpoint inhibitor Performance status Urothelial carcinoma

Humans *Carcinoma Transitional Cell/drug therapy *Urinary Bladder Neoplasms/pathology *Urologic Neoplasms/drug therapy/pathology Antibodies Monoclonal/adverse effects

Bladder-sparing strategy Clinical complete response Localized muscle-invasive bladder cancer Neoadjuvant Systemic treatment

Humans Aged Cystectomy/methods *Urinary Bladder Neoplasms/surgery Urinary Bladder *Urinary Diversion/methods Hospital Mortality Bladder cancer Complications Epidemiology Mortality Radical cystectomy Urinary diversions

Humans *Urinary Bladder Neoplasms *Carcinoma Transitional Cell/surgery/pathology Ureteroscopy/adverse effects/methods *Ureteral Neoplasms/surgery/pathology *Kidney Neoplasms/surgery/pathology Antegrade Endoscopic surgery Kidney-sparing surgery Retrograde Upper tract urothelial carcinoma

Male Humans *Stomach Neoplasms/genetics *Urinary Bladder Neoplasms/genetics Urinary Bladder Membrane Proteins RNA Messenger Antigens Neoplasm/genetics Neoplasm Proteins GPI-Linked Proteins/genetics Psca cancer risk polymorphism rs2294008 (C/T)

Humans *Transurethral Resection of Bladder Neoplasm Recurrence Local/pathology *Urinary Bladder Neoplasms/diagnosis/surgery/pathology Prognosis Urologic Surgical Procedures Cystectomy Bladder cancer Css Os Pfs Rfs Transurethral resection of bladder tumors financial ties to disclose.

Bcg Instillation Intravesical Low dose Non–muscle-invasive bladder cancer

Humans *Urinary Diversion/adverse effects *Ureter/surgery Cystectomy/methods Anastomosis Surgical/adverse effects *Vesico-Ureteral Reflux/etiology *Urinary Bladder Neoplasms/surgery Ileum/surgery *Pyelonephritis/complications Bladder Orthotopic ileal neobladder Radical cystectomy Tumor Ureteroenteric anastomosis Urinary diversion

Humans *Carcinoma Transitional Cell/pathology *Urinary Bladder Neoplasms/genetics DNA Methylation Neoplasm Recurrence Local/genetics Prognosis *Urologic Neoplasms/genetics/pathology Membrane Proteins/genetics Neoplasm Proteins/genetics Biomarkers Kaplan-Meier survival Meta-analysis Methylation Upper tract urothelial carcinoma

Humans *Gemcitabine Docetaxel/therapeutic use BCG Vaccine/adverse effects Adjuvants Immunologic *Urinary Bladder Neoplasms/therapy Administration Intravesical Neoplasm Invasiveness Neoplasm Recurrence Local

Humans *BCG Vaccine/adverse effects *Urinary Bladder Neoplasms/drug therapy BCG vaccine administration intravesical systematic review urinary bladder neoplasms

Humans Cystectomy/adverse effects/methods *Urinary Bladder Neoplasms/surgery/etiology Urinary Bladder *Urinary Diversion/adverse effects/methods *Acidosis/epidemiology/etiology/therapy Acidosis metabólica Bicarbonate Bicarbonato Bladder tumor Cistectomía radical Derivación urinaria Metabolic acidosis Radical cystectomy Tratamiento Treatment Tumor vesical Urinary diversion